Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction (Q44828167)

6 December 2017

title

Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction (English)

1 reference

6 December 2017

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

mesenchymal stem cell

1 reference

Lin Fan

1

1 reference

6 December 2017

Chaogui Lin

2

1 reference

6 December 2017

Shuangmu Zhuo

3

1 reference

6 December 2017

Lianglong Chen

4

1 reference

6 December 2017

Nan Liu

5

1 reference

6 December 2017

Yukun Luo

6

1 reference

6 December 2017

Jun Fang

7

1 reference

6 December 2017

Zhengrong Huang

8

1 reference

6 December 2017

Yunling Lin

9

1 reference

6 December 2017

Jianxin Chen

10

1 reference

6 December 2017

publication date

1 November 2009

1 reference

European Journal of Heart Failure

6 December 2017

published in

1 reference

6 December 2017

volume

11

1 reference

6 December 2017

issue

11

1 reference

6 December 2017

page(s)

1023-1030

1 reference

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Lentiviral vectors: turning a deadly foe into a therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Experimental validation of a new ultrasound method for the simultaneous assessment of radial and longitudinal myocardial deformation independent of insonation angle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURJHF/HFP135

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP135

1 reference

6 December 2017

1 reference